OTC · Financial Statements
Orgenesis Inc. (ORGS) Financial Statements
$0.11
OTC: ORGS
Market Cap $568618
Overview Financials Dividend
Orgenesis Inc. most recently reported annual revenue of $1.0M, a net loss of $55.0M. Revenue declined at an average annual rate of 44.5% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023
Revenue $33.0M $8.0M $36.0M $36.0M $1.0M Operating Profit $-25.0M $-96.0M $-17.0M $-8.0M $-54.0M Net Profit $-26.0M $-96.0M $-18.0M $-15.0M $-55.0M EPS $-1.64 $-4.46 $-0.74 $-0.59 $-1.91 Op Margin -74.0% -1251.7% -47.3% -20.9% -10120.0%
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023
Total Assets $92.0M $78.0M $60.0M $91.0M $15.0M Total Liabilities $86.0M $25.0M $21.0M $32.0M $36.0M Cash $11.0M $45.0M $5.0M $5.0M $1.0M Borrowings $25.0M $13.0M $12.0M $20.0M $23.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023
Operating Cash Flow $-13.0M $-78.0M $-27.0M $-25.0M $-15.0M Investing Cash Flow $-26.0M $104.0M $-20.0M $-27.0M $-7.0M Financing Cash Flow $13.0M $0 $-1.0M $21.0M $5.0M Net Cash Flow $-3.0M $34.0M $-40.0M $0 $-5.0M Free Cash Flow $-25.0M $-80.0M $-35.0M $-37.0M $-17.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.37 FCF Yield -2977.92% Quick Ratio 0.25 Interest Coverage -24.75 Return 1Y -60.40% Return 3Y -96.33% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .